Annemarie Wensing, MD, PhD is a leading clinical virologist at the University Medical Center Utrecht, head of the microbiology training program and lecturer at the Medical School. She is a Honorary Professor of the University of the Witwatersrand in Johannesburg in South Africa. She consults on clinical management of HIV drug resistance for multiple HIV centers. She is advisor for the WHO HIV resistance network and chair of the international Panel that assesses HIV–1 Drug Resistance mutations (IAS–USA). She is principal investigator of various international studies and collaborations and steering committee member of the Ndlovu Research Consortium. She is a governing board member of the European AIDS Clinical Society (EACS) and Chair European HIV drug resistance surveillanceprogram SPREAD. She is a member of the organising committee of the international HIV Drug Resistance Workshop and an active member of serval guideline committees. Annemarie is (co–) principal investigator of international collaborative HIV cure projects such as the IciStem consortium (www.IciStem.org) and the post–mortem FIND study at WITS university. Together with Monique Nijhuis she steers the Translational Virology Research Group at the University Medical Center Utrecht. Annemarie published over 150 original papers in peer reviewed journals.

Dr. Wensing will assist in setting up the clinical interpretation and the clinical response system and participate as expert in the clinical video calls. She will oversee the drug resistance surveillance strategy, applied scientific projects and have an active role in dissemination and education.